Sanofi

Lilly swoops on Dermira to claim Dupixent rival

https://pharmaphorum.com/news/lilly-swoops-on-dermira-to-claim-dupixent-rival/

Sanofi Genzyme UK medical boss Marc Moodley discusses oncology plans, NICE and Brexit

https://pharmaphorum.com/views-analysis-oncology/sanofi-genzyme-uk-medical-boss-marc-moodley-discusses-oncology-plans-nice-and-brexit/

Sanofi axes diabetes R&D, focuses on ‘transformative’ therapies

https://pharmaphorum.com/news/sanofi-axes-diabetes-and-cardio-rd-shifts-focus-on-transformative-therapies/

Sanofi snaps up Synthorx for $2.5bn, eyeing cancer immunotherapy combinations

https://pharmaphorum.com/news/sanofi-snaps-up-synthorx-for-2-5bn-eyeing-cancer-immunotherapy-combinations/

Sanofi presents “Implementation Eats Strategy for Breakfast”

https://pharmaphorum.com/partner-content/sanofi-presents-implementation-eats-strategy-for-breakfast/

Experts concerned over mixed results from Takeda’s dengue vaccine

https://pharmaphorum.com/news/experts-concerned-over-mixed-results-from-takedas-dengue-vaccine/

Sanofi builds case for Toujeo in younger type 1 diabetics

https://pharmaphorum.com/news/sanofi-builds-case-for-toujeo-in-younger-type-1-diabetics/

Sanofi settles dispute with Genzyme investors over MS drug

https://pharmaphorum.com/news/sanofi-settles-dispute-with-genzyme-investors-over-ms-drug/

Regeneron/Sanofi get EU okay for Dupixent in “asthma of the sinuses”

https://pharmaphorum.com/news/regeneron-sanofi-get-eu-okay-for-dupixent-in-asthma-of-the-sinuses/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search